Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Pediatrics. 2009.
PMID: 19948625
Clinical Trial.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 0 |
Search Results
36 results
Results by year
Citations
2
articles
found by citation matching
Emerging role of aripiprazole for treatment of irritability associated with autistic disorder in children and adolescents.
Adolesc Health Med Ther. 2010.
PMID: 24600266
Free PMC article.
Review.
Search results
Page 1
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
Pharmacotherapy. 2019 Jun;39(6):626-635. doi: 10.1002/phar.2271. Epub 2019 May 29.
Pharmacotherapy. 2019.
PMID: 31063671
Free PMC article.
Clinical Trial.
The objective of this trial, Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART), was to provide support and guidance for an evidence-based approach for the selection and monitoring of initial pharmacotherapy in patients with autism by assessing p …
The objective of this trial, Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART), was to provide support an …
Emerging role of aripiprazole for treatment of irritability associated with autistic disorder in children and adolescents.
Adolesc Health Med Ther. 2010 Sep 15;1:105-14. doi: 10.2147/AHMT.S9819. eCollection 2010.
Adolesc Health Med Ther. 2010.
PMID: 24600266
Free PMC article.
Review.
Atypical antipsychotics have often been used in the treatment of autistic disorder to target irritability, aggression, and self-injurious behavior, all of which can interfere with other aspects of treatment. One atypical antipsychotic, aripip …
Atypical antipsychotics have often been used in the treatment of autistic disorder to target irritability, aggre …
Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.
Indian J Med Res. 2015 Sep;142(3):269-75. doi: 10.4103/0971-5916.166584.
Indian J Med Res. 2015.
PMID: 26458342
Free PMC article.
Review.
All the double-blind, controlled, randomized, clinical trials examining the efficacy of aripiprazole for treating children and adolescents with autism were included. ...The evidence from precise randomized double blind clinical trials of aripiprazole f …
All the double-blind, controlled, randomized, clinical trials examining the efficacy of aripiprazole for treating children and …
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Pediatrics. 2009 Dec;124(6):1533-40. doi: 10.1542/peds.2008-3782.
Pediatrics. 2009.
PMID: 19948625
Clinical Trial.
OBJECTIVE: The objective of this study was to evaluate short-term efficacy and safety of aripiprazole in the treatment of irritability in children and adolescents with autistic disorder who were manifesting behaviors such as tantru …
OBJECTIVE: The objective of this study was to evaluate short-term efficacy and safety of aripiprazole in the treatment of i …
Long-Term Improvement and Safety of Aripiprazole for Irritability and Adaptive Function in Asian Children and Adolescents with Autistic Disorder: A 52-Week, Multinational, Multicenter, Open-Label Study.
J Child Adolesc Psychopharmacol. 2022 Sep;32(7):390-399. doi: 10.1089/cap.2022.0004.
J Child Adolesc Psychopharmacol. 2022.
PMID: 36112116
Objective: Evaluate the long-term improvement and safety of aripiprazole in treating irritability in Asian children and adolescents (6-17 years) with autistic disorder. Methods: A 52-week, open-label, flexibly dosed (2-15 mg/day) study on …
Objective: Evaluate the long-term improvement and safety of aripiprazole in treating irritability in Asian children and …
Treatment of Autism Spectrum Disorder in Children and Adolescents.
Psychopharmacol Bull. 2016 Aug 15;46(2):18-41.
Psychopharmacol Bull. 2016.
PMID: 27738378
Free PMC article.
Children and adolescents with autism spectrum disorder appear to be more susceptible to adverse effects with medications; therefore, initiation with low doses and titrating very slowly is recommended. Some complementary alternative treatments have been …
Children and adolescents with autism spectrum disorder appear to be more susceptible to adverse effects with medication …
Autism Spectrum Disorder and Complementary-Integrative Medicine.
Child Adolesc Psychiatr Clin N Am. 2023 Apr;32(2):469-494. doi: 10.1016/j.chc.2022.08.004.
Child Adolesc Psychiatr Clin N Am. 2023.
PMID: 37147047
Review.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 0.6%-1.7% of children. ...The perceived safety of CIM treatments as "natural treatment" over allopathic medication increases parental comfort in using these agents. ...
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 0.6%-1.7% of children. ...The perceived sa …
An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.
Psychiatry Clin Neurosci. 2018 Feb;72(2):84-94. doi: 10.1111/pcn.12607. Epub 2017 Nov 8.
Psychiatry Clin Neurosci. 2018.
PMID: 28941259
Free article.
AIM: The purpose of this study was to evaluate the long-term safety and efficacy of aripiprazole in treating irritability in pediatric patients (6-17 years) with autistic disorder (AD) in Japan. ...CONCLUSION: Aripiprazole was generally safe, we …
AIM: The purpose of this study was to evaluate the long-term safety and efficacy of aripiprazole in treating irritability in p …
Aripiprazole for Irritability in Asian Children and Adolescents with Autistic Disorder: A 12-Week, Multinational, Multicenter, Prospective Open-Label Study.
J Child Adolesc Psychopharmacol. 2018 Jul/Aug;28(6):402-408. doi: 10.1089/cap.2017.0152. Epub 2018 Apr 24.
J Child Adolesc Psychopharmacol. 2018.
PMID: 29688754
OBJECTIVES: We investigated the effectiveness and tolerability of aripiprazole in the treatment of irritability in Asian children and adolescents (6-17 years) with autistic disorder in a 12-week, multinational, multicenter, open-la …
OBJECTIVES: We investigated the effectiveness and tolerability of aripiprazole in the treatment of irritability in Asia …
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
J Clin Psychiatry. 2008;69 Suppl 4:15-20.
J Clin Psychiatry. 2008.
PMID: 18533764
Review.
Atypical antipsychotics are emerging as the first-line pharmacologic treatment for irritability (i.e., aggression, self-injurious behavior, and severe tantrums) in children and adolescents with autistic and other pervasive developmental disorder …
Atypical antipsychotics are emerging as the first-line pharmacologic treatment for irritability (i.e., aggression, self-injuri …
Cite